Annual SGA
$6.99 M
+$607.00 K+9.51%
June 30, 2024
Summary
- As of February 7, 2025, BNTC annual SGA is $6.99 million, with the most recent change of +$607.00 thousand (+9.51%) on June 30, 2024.
- During the last 3 years, BNTC annual SGA has risen by +$477.00 thousand (+7.32%).
- BNTC annual SGA is now -20.09% below its all-time high of $8.75 million, reached on June 30, 2016.
Performance
BNTC SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$2.21 M
+$170.00 K+8.35%
September 30, 2024
Summary
- As of February 7, 2025, BNTC quarterly SGA is $2.21 million, with the most recent change of +$170.00 thousand (+8.35%) on September 30, 2024.
- Over the past year, BNTC quarterly SGA has increased by +$382.00 thousand (+20.94%).
- BNTC quarterly SGA is now -30.29% below its all-time high of $3.16 million, reached on December 31, 2015.
Performance
BNTC Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$751.14 M
-$21.48 M-2.94%
September 30, 2024
Summary
- As of February 7, 2025, BNTC TTM SGA is -$751.14 million, with the most recent change of -$21.48 million (-2.94%) on September 30, 2024.
- Over the past year, BNTC TTM SGA has dropped by -$757.11 million (-12673.45%).
- BNTC TTM SGA is now -640.15% below its all-time high of -$101.48 million.
Performance
BNTC TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
BNTC Selling, General & Administrative Expenses Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +9.5% | +20.9% | -10000.0% |
3 y3 years | +7.3% | +20.9% | -10000.0% |
5 y5 years | +51.5% | +20.9% | -10000.0% |
BNTC Selling, General & Administrative Expenses Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | at high | +9.5% | at high | +79.6% | -41.4% | at low |
5 y | 5-year | at high | +51.5% | at high | +114.4% | -544.0% | at low |
alltime | all time | -20.1% | +59.4% | -30.3% | +194.1% | -640.1% | at low |
Benitec Biopharma Selling, General & Administrative Expenses History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | - | $2.21 M(+8.3%) | $7.64 M(+9.4%) |
Jun 2024 | $6.99 M(+9.5%) | $2.04 M(+29.0%) | $6.99 M(+10.5%) |
Mar 2024 | - | $1.58 M(-13.5%) | $6.32 M(+5.9%) |
Dec 2023 | - | $1.82 M(+17.6%) | $5.97 M(-0.6%) |
Sep 2023 | - | $1.55 M(+13.1%) | $6.01 M(-5.8%) |
Jun 2023 | $6.38 M(-4.0%) | $1.37 M(+11.6%) | $6.38 M(-2.8%) |
Mar 2023 | - | $1.23 M(-34.1%) | $6.56 M(-1.6%) |
Dec 2022 | - | $1.86 M(-3.0%) | $6.67 M(+2.3%) |
Sep 2022 | - | $1.92 M(+23.6%) | $6.52 M(-1.8%) |
Jun 2022 | $6.65 M(+2.1%) | $1.55 M(+16.2%) | $6.65 M(+0.3%) |
Mar 2022 | - | $1.34 M(-22.0%) | $6.63 M(+4.9%) |
Dec 2021 | - | $1.71 M(-16.1%) | $6.32 M(-5.9%) |
Sep 2021 | - | $2.04 M(+32.9%) | $6.72 M(+3.1%) |
Jun 2021 | $6.51 M(+17.0%) | $1.54 M(+49.3%) | $6.51 M(-5.3%) |
Mar 2021 | - | $1.03 M(-51.3%) | $6.88 M(-3.6%) |
Dec 2020 | - | $2.11 M(+14.9%) | $7.13 M(+3.1%) |
Sep 2020 | - | $1.84 M(-3.2%) | $6.92 M(+18.6%) |
Jun 2020 | $5.57 M | $1.90 M(+47.5%) | $5.83 M(+48.3%) |
Mar 2020 | - | $1.29 M(-32.1%) | $3.93 M(+48.7%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2019 | - | $1.90 M(+152.7%) | $2.65 M(+252.7%) |
Sep 2019 | - | $750.00 K(-47.2%) | $750.00 K(-88.3%) |
Jun 2019 | $4.61 M(-28.0%) | - | - |
Jun 2018 | $6.41 M(-8.3%) | $1.42 M(-13.0%) | $6.41 M(-3.7%) |
Mar 2018 | - | $1.63 M(-0.5%) | $6.66 M(-3.9%) |
Dec 2017 | - | $1.64 M(-4.6%) | $6.93 M(-1.5%) |
Sep 2017 | - | $1.72 M(+3.0%) | $7.04 M(+0.7%) |
Jun 2017 | $6.99 M(-20.1%) | $1.67 M(-12.3%) | $6.99 M(+3.3%) |
Mar 2017 | - | $1.90 M(+9.0%) | $6.77 M(-4.7%) |
Dec 2016 | - | $1.75 M(+4.5%) | $7.10 M(-16.6%) |
Sep 2016 | - | $1.67 M(+15.6%) | $8.52 M(-2.5%) |
Jun 2016 | $8.75 M(+41.7%) | $1.45 M(-35.4%) | $8.75 M(-4.8%) |
Mar 2016 | - | $2.24 M(-29.2%) | $9.19 M(+13.5%) |
Dec 2015 | - | $3.16 M(+67.1%) | $8.10 M(+64.2%) |
Sep 2015 | - | $1.89 M(+0.1%) | $4.93 M(+62.3%) |
Jun 2015 | $6.17 M(-19.5%) | $1.89 M(+64.9%) | $3.04 M(+164.9%) |
Mar 2015 | - | $1.15 M | $1.15 M |
Jun 2014 | $7.67 M(+74.8%) | - | - |
Jun 2013 | $4.38 M | - | - |
FAQ
- What is Benitec Biopharma annual SGA?
- What is the all time high annual SGA for Benitec Biopharma?
- What is Benitec Biopharma annual SGA year-on-year change?
- What is Benitec Biopharma quarterly SGA?
- What is the all time high quarterly SGA for Benitec Biopharma?
- What is Benitec Biopharma quarterly SGA year-on-year change?
- What is Benitec Biopharma TTM SGA?
- What is the all time high TTM SGA for Benitec Biopharma?
- What is Benitec Biopharma TTM SGA year-on-year change?
What is Benitec Biopharma annual SGA?
The current annual SGA of BNTC is $6.99 M
What is the all time high annual SGA for Benitec Biopharma?
Benitec Biopharma all-time high annual SGA is $8.75 M
What is Benitec Biopharma annual SGA year-on-year change?
Over the past year, BNTC annual SGA has changed by +$607.00 K (+9.51%)
What is Benitec Biopharma quarterly SGA?
The current quarterly SGA of BNTC is $2.21 M
What is the all time high quarterly SGA for Benitec Biopharma?
Benitec Biopharma all-time high quarterly SGA is $3.16 M
What is Benitec Biopharma quarterly SGA year-on-year change?
Over the past year, BNTC quarterly SGA has changed by +$382.00 K (+20.94%)
What is Benitec Biopharma TTM SGA?
The current TTM SGA of BNTC is -$751.14 M
What is the all time high TTM SGA for Benitec Biopharma?
Benitec Biopharma all-time high TTM SGA is -$101.48 M
What is Benitec Biopharma TTM SGA year-on-year change?
Over the past year, BNTC TTM SGA has changed by -$757.11 M (-12673.45%)